Mesothelioma Risk Among Navy Veterans is Focus of New Report
A new study offers a sobering reminder of the mesothelioma risk among Navy veterans. Researchers at Vanderbilt University compared mesothelioma…
Immunotherapy for Peritoneal Mesothelioma: New Drug Trial Begin
Researchers in Maryland and Missouri have started human testing of a new type of immunotherapy for peritoneal mesothelioma. If the…
Asbestos | Asia | Diagnosis | International | New Techniques | Prognosis
Japanese Discovery Could Lead to New Mesothelioma Blood Test
A discovery in Japan could lead to a more effective mesothelioma blood test for mesothelioma diagnosis. Japanese scientists say they…
Biomarkers | Diagnosis | Genetics | New Drugs | Research | Treatments
Genetics-Based Cancer Treatment Could Mean New Hope for Mesothelioma
The FDA has approved a new genetics-based cancer treatment that could open the door for more targeted mesothelioma therapy. The…
Radiation May Help Mesothelioma Immunotherapy Treatment Work Better
Hypofractionated radiation for mesothelioma could change how doctors treat this rare cancer. Researchers in Toronto, Canada have been testing hypofractionated…
Acupuncture for Cancer May Relieve Mesothelioma Symptoms
There is new evidence that acupuncture may help relieve some of the worst symptoms of cancer and cancer treatment. The…
Alternatives | Chemotherapy | Europe | International | New Drugs | New Studies | Research | Treatments
Study Suggests Sugar Supplement Could Slow Growth of Mesothelioma
A sugar supplement might be able to slow the growth of mesothelioma and others types of cancer. The sugar supplement…
Mesothelioma Surgery PD Comparison
Lung-sparing surgery is another name for pleurectomy/decortication (PD). In PD, surgeons take out as much mesothelioma cancer as they can…
Belgian Mesothelioma Survival Study
A new Belgian mesothelioma survival study contains important insights for patients and doctors. Cancer center researchers did the study with…
Alternatives | Asia | International | New Drugs | Treatments
When Chemotherapy Fails: Apatinib May Offer Third-Line Option for Mesothelioma Patients
An investigational drug being developed in China may offer a third lifeline to mesothelioma patients whose cancer does not respond…